Dementia treatment medicine

Neurodegenerative diseases caused by dementia are a massive burden on the community. Dr Siew Yeen Chai from the Florey Neuroscience Institute is on the way to developing and refining a new drug to treat learning and memory loss, especially in dementia patients. 

Funding assistance from Commercialisation Australia will facilitate collaboration between the Florey Neuroscience Institute (a registered eligible partner entity) and a biopharma company to further develop this work.